Medicare Enrolled

Dr. Paul Friedman, MD

Pulmonary Disease · Manasquan, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2640 HIGHWAY 70, Manasquan, NJ 08736
7325285900
Registered in NPPES since 2005
NPI: 1386646040 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Friedman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friedman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Friedman

Dr. Paul Friedman is a pulmonary disease specialist in Manasquan, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Friedman performed 2,747 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Friedman received a total of $64,001 from 31 pharmaceutical and/or device companies across 783 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Friedman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration ▲ Top 21% volume in NJ $64,001 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,747
Medicare services
Top 21% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
964 $22 $41
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
927 $72 $139
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
196 $102 $193
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
143 $32 $65
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
139 $37 $73
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
139 $49 $93
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
99 $133 $250
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $41 $85
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
67 $29 $55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$64,001
Total received (2018-2024)
Avg $9,143/year across 7 years
Top 4% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
783
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,748
2023
$2,094
2022
$5,945
2021
$20,122
2020
$12,845
2019
$13,733
2018
$7,513

Payments by company (2024)

GlaxoSmithKline, LLC.
$497
AstraZeneca Pharmaceuticals LP
$477
GENZYME CORPORATION
$250
United Therapeutics Corporation
$156
Regeneron Healthcare Solutions, Inc.
$104
Amgen Inc.
$67
Mylan Specialty L.P.
$55
Baxter Healthcare
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Shionogi Inc
$18
Novartis Pharmaceuticals Corporation
$17
Philips North America LLC
$17
Grifols USA, LLC
$15
Harmony Biosciences Llc
$9
Top 3 companies account for 70.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$48,845
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,684
AstraZeneca Pharmaceuticals LP
$2,627
Philips Electronics North America Corporation
$1,152
Regeneron Healthcare Solutions, Inc.
$804
GENZYME CORPORATION
$680
Amgen Inc.
$385
Mylan Specialty L.P.
$364
Actelion Pharmaceuticals US, Inc.
$289
United Therapeutics Corporation
$211
Electromed, Inc.
$158
Sunovion Pharmaceuticals Inc.
$144
Genentech USA, Inc.
$138
Covis Pharma GmBH
$107
Novartis Pharmaceuticals Corporation
$79
Grifols USA, LLC
$53
Baxter Healthcare
$52
Teva Pharmaceuticals USA, Inc.
$38
Insmed, Inc.
$28
Shionogi Inc
$18
Philips North America LLC
$17
Bayer Healthcare Pharmaceuticals Inc.
$14
Janssen Pharmaceuticals, Inc
$14
JAZZ PHARMACEUTICALS INC.
$14
Harmony Biosciences LLC
$14
Jazz Pharmaceuticals Inc.
$14
Mallinckrodt Hospital Products Inc.
$13
SANOFI PASTEUR INC.
$13
Optinose US, Inc.
$12
PFIZER INC.
$12
Harmony Biosciences Llc
$9
Top 3 companies account for 92.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADACEL · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · DUPIXENT · Esbriet · FASENRA · Fetroja · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 13 · Perforomist · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYWAV · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Manasquan?
Compare pulmonary diseases in the Manasquan area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
44
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
OCEAN MEDICAL CENTER
3.8 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Friedman is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NJ), with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Friedman experienced with expiratory airflow and volume test?
Based on Medicare claims data, Dr. Friedman performed 964 expiratory airflow and volume test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Friedman receive payments from pharmaceutical companies?
Yes. Dr. Friedman received a total of $64,001 from 31 companies across 783 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Friedman's costs compare to other pulmonary diseases in Manasquan?
Dr. Friedman's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Friedman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →